These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 24844135)

  • 41. Exosomes - structure, biogenesis and biological role in non-small-cell lung cancer.
    Frydrychowicz M; Kolecka-Bednarczyk A; Madejczyk M; Yasar S; Dworacki G
    Scand J Immunol; 2015 Jan; 81(1):2-10. PubMed ID: 25359529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNAs and cancer--new paradigms in molecular oncology.
    Negrini M; Nicoloso MS; Calin GA
    Curr Opin Cell Biol; 2009 Jun; 21(3):470-9. PubMed ID: 19411171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.
    Zen K; Zhang CY
    Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNAs in clinical oncology: at the crossroads between promises and problems.
    Metias SM; Lianidou E; Yousef GM
    J Clin Pathol; 2009 Sep; 62(9):771-6. PubMed ID: 19734473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The miR-183 Cluster: Biogenesis, Functions, and Cell Communication via Exosomes in Cancer.
    Li S; Meng W; Guo Z; Liu M; He Y; Li Y; Ma Z
    Cells; 2023 May; 12(9):. PubMed ID: 37174715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.
    Rupaimoole R; Calin GA; Lopez-Berestein G; Sood AK
    Cancer Discov; 2016 Mar; 6(3):235-46. PubMed ID: 26865249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: state of the art and new perspectives.
    Fontana S; Saieva L; Taverna S; Alessandro R
    Proteomics; 2013 May; 13(10-11):1581-94. PubMed ID: 23401131
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNAs as prognostic markers in ovarian cancer.
    Llauradó M; Majem B; Altadill T; Lanau L; Castellví J; Sánchez-Iglesias JL; Cabrera S; De la Torre J; Díaz-Feijoo B; Pérez-Benavente A; Colás E; Olivan M; Doll A; Alameda F; Matias-Guiu X; Moreno-Bueno G; Carey MS; Del Campo JM; Gil-Moreno A; Reventós J; Rigau M
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):73-84. PubMed ID: 24747602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential of microRNAs for cancer diagnostics, prognostication and therapy.
    Garzon R; Marcucci G
    Curr Opin Oncol; 2012 Nov; 24(6):655-9. PubMed ID: 23079782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exosomal microRNA: a diagnostic marker for lung cancer.
    Rabinowits G; Gerçel-Taylor C; Day JM; Taylor DD; Kloecker GH
    Clin Lung Cancer; 2009 Jan; 10(1):42-6. PubMed ID: 19289371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
    Weiland M; Gao XH; Zhou L; Mi QS
    RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exosomes: Emerging biomarkers and targets for ovarian cancer.
    Tang MK; Wong AS
    Cancer Lett; 2015 Oct; 367(1):26-33. PubMed ID: 26189430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. microRNA biomarkers in body fluids of prostate cancer patients.
    Kuner R; Brase JC; Sültmann H; Wuttig D
    Methods; 2013 Jan; 59(1):132-7. PubMed ID: 22652624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNAs in cancer management and their modulation by dietary agents.
    Karius T; Schnekenburger M; Dicato M; Diederich M
    Biochem Pharmacol; 2012 Jun; 83(12):1591-601. PubMed ID: 22342289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of microRNAs in the management of liver cancer.
    Banaudha KK; Verma M
    Methods Mol Biol; 2012; 863():241-51. PubMed ID: 22359297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNAs and future therapeutic applications in cancer.
    Casalini P; Iorio MV
    J BUON; 2009 Sep; 14 Suppl 1():S17-22. PubMed ID: 19785062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNAs in breast cancer pathogenesis.
    Götte M
    Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.
    Kohlhapp FJ; Mitra AK; Lengyel E; Peter ME
    Oncogene; 2015 Nov; 34(48):5857-68. PubMed ID: 25867073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC
    Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic exchanges within tumor microenvironment.
    Chiarugi P; Cirri P
    Cancer Lett; 2016 Sep; 380(1):272-80. PubMed ID: 26546872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.